Summary

Asia Pacific Bio-implants Market is valued at approximately USD 39.84 Billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.15 % over the forecast period 2024-2032. Bio-implants are medical devices or tissues that are surgically inserted into the body to replace, support, or enhance biological functions. They can be made from synthetic materials, natural tissues, or a combination of both and are used in various applications, including orthopedic, dental, and cardiovascular treatments. These devices range widely in complexity and purpose, from basic dental implants to advanced systems such as pacemakers, artificial joints, and neural implants. One of the primary goals of bioimplants is to improve the quality of life for individuals suffering from various illnesses or injuries by utilizing implantable devices to recover functions that are lost or impaired. Commonly made of biocompatible materials, bio-implants lower the chances of being rejected by the host's immune system. The market is receiving more focus because of developments such as incorporating sensors and wireless connections in bioimplants, which allow for monitoring physiological data in real-time and adjusting from a distance. Moreover, the Asia Pacific Bio-implants Market growth is further propelled by the incorporation of biocompatible materials in bioimplants, reducing the chances of rejection by the body's immune system.

Various factors such as technological advancements, growing prevalence of chronic diseases, growing ageing population, and rising demand for minimally invasive surgeries are driving the Asia Pacific Bio-implants Market. Technological advancements are a major factor in the creation of advanced implants with improved features such as integrated sensors and wireless connection, as they have become more sophisticated and biocompatible. These advancements enhance patient outcomes by enabling real-time monitoring and remote adjustments. However, the market encounters limitations such as expensive bioimplants, strict regulatory demands, and possible complications associated with implant surgeries. These obstacles may restrict the availability and acceptance of bioimplants, affecting the overall expansion of the Asia Pacific Bio-implants Market.

The key Countries considered for the Asia Pacific Bio-implants Market study include China, India, Japan, South Korea, Australia and the Rest of Asia Pacific. In the Asia Pacific Bio-implants market, China is the dominating region in terms of revenue due to its large population, advanced healthcare infrastructure, and significant investments in medical research and development. The region’s growing economy and increasing healthcare expenditure contribute to the high demand for bio-implants. Additionally, the presence of leading bio-implant manufacturers and the rapid adoption of innovative medical technologies bolster China’s dominance in the market. Furthermore, government initiatives to enhance healthcare access and affordability, along with rising disposable incomes, support the accelerated adoption of bio-implants in China. The market in India, on the other hand, is expected to grow at the fastest rate over the forecast period.

Major market players included in this report are:
Asahi Intecc Co., Ltd.
Lifehealthcare Group Limited
Terumo Corporation
Corentec Co., Ltd.
Fisher & Paykel Healthcare Limited
Kyocera Corporation
Tianjin Walkman Biomaterial Co., Ltd
Neobiotech Co., Ltd.
Santen Pharmaceutical Co., Ltd.
megagen implant co. ltd

The detailed segments and sub-segments of the market are explained below:

By Type
Dental Bio-implants
Orthopedic Bio-implants
Spinal Bio-implants
Ophthalmology Bio-implants
Cardiovascular Bio-implants
Others
By End User
Hospitals
Speciality Clinics
Ambulatory surgical centres
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Asia Pacific Bio-implants Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Asia Pacific Bio-implants Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Type
2.3.2. By End User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Bio-implants Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Bio-implants Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Bio-implants Market Size & Forecasts by Type 2022-2032
5.1. Dental Bio-implants
5.2. Orthopedic Bio-implants
5.3. Spinal Bio-implants
5.4. Ophthalmology Bio-implants
5.5. Cardiovascular Bio-implants
5.6. Others
Chapter 6. Asia Pacific Bio-implants Market Size & Forecasts by End User 2022-2032
6.1. Hospitals
6.2. Speciality Clinics
6.3. Ambulatory surgical centres
Chapter 7. Asia Pacific Bio-implants Market Size & Forecasts by Country 2022-2032
7.1. China Bio-implants Market
7.1.1. Type breakdown size & forecasts, 2022-2032
7.1.2. End User breakdown size & forecasts, 2022-2032
7.2. India Bio-implants Market
7.3. Japan Bio-implants Market
7.4. Australia Bio-implants Market
7.5. South Korea Bio-implants Market
7.6. Rest of Asia Pacific Bio-implants Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Asahi Intecc Co., Ltd.
8.1.2. Lifehealthcare Group Limited
8.1.3. Terumo Corporation
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Asahi Intecc Co., Ltd.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Lifehealthcare Group Limited
8.3.3. Terumo Corporation
8.3.4. Corentec Co., Ltd.
8.3.5. Fisher & Paykel Healthcare Limited
8.3.6. Kyocera Corporation
8.3.7. Tianjin Walkman Biomaterial Co., Ltd
8.3.8. Neobiotech Co., Ltd.
8.3.9. Santen Pharmaceutical Co., Ltd.
8.3.10. megagen implant co. ltd
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes